Instil Bio

TILNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$47.881 M

$7.06 +1.00%

Close of 6 Nov 2026

As of 6 Nov 2026, Instil Bio (TIL) has a market capitalization of $47.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$71.4M

Loss-making

Shares outstanding

6,781,976

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#124MiNK TherapeuticsINKT$50.7M
#125Greenland MinesGRML$49.3M
#126Instil BioTIL$47.9M
#127ImageneBioIMA$46.2M
#128Caribou BiosciencesCRBU$44.2M

What if Instil Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,163,517

Per share 589,733× higher

Bitcoin $1.53T

$225,280.66

Per share 31,909× higher

Apple $5.02T

$739,575.39

Per share 104,756× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Instil Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.